This inventor holds 1 USPTO granted patent. Top assignee: Obigen Pharma, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Yung-Kai Wang: Innovator in Botulinum Toxin Complexes
Introduction
Yung-Kai Wang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of botulinum toxin complexes. His innovative work has the potential to enhance safety and efficacy in medical treatments.
Latest Patents
Yung-Kai Wang holds a patent for a botulinum toxin type A complex, which includes a formulation and usage method. This invention provides a botulinum toxin type A complex that comprises several components, including HA70, HA17, HA33, NINH, and BoNT/A1. The molecular weight of this complex ranges from 740 to 790 kDa. Compared to existing botulinum toxin complexes, Wang's invention is smaller in molecular weight and offers higher safety while maintaining comparable treatment effects.
Career Highlights
Wang is associated with Obigen Pharma, Inc., where he continues to advance his research and development efforts. His work is pivotal in the ongoing evolution of therapeutic applications for botulinum toxins.
Collaborations
Yung-Kai Wang collaborates with talented individuals such as Tzu-Wen Tsau and Kuan-Cheng Shen. Their combined expertise contributes to the innovative projects at Obigen Pharma, Inc.
Conclusion
Yung-Kai Wang's contributions to the field of botulinum toxin complexes exemplify the impact of innovation in biotechnology. His work not only enhances treatment safety but also opens new avenues for medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile